Selecta Biosciences Net Income 2015-2021 | SELB

Selecta Biosciences net income from 2015 to 2021. Net income can be defined as company's net profit or loss after all revenues, income items, and expenses have been accounted for.
Selecta Biosciences Annual Net Income
(Millions of US $)
2020 $-69
2019 $-55
2018 $-65
2017 $-65
2016 $-36
2015 $-33
2014 $-16
Selecta Biosciences Quarterly Net Income
(Millions of US $)
2021-06-30 $5
2021-03-31 $-25
2020-12-31 $-15
2020-09-30 $-10
2020-06-30 $-24
2020-03-31 $-20
2019-12-31 $-15
2019-09-30 $-12
2019-06-30 $-16
2019-03-31 $-12
2018-12-31 $-15
2018-09-30 $-16
2018-06-30 $-19
2018-03-31 $-16
2017-12-31 $-20
2017-09-30 $-15
2017-06-30 $-16
2017-03-31 $-15
2016-12-31 $-10
2016-09-30 $-8
2016-06-30 $-9
2016-03-31 $-10
2015-12-31
2015-09-30 $-8
2015-06-30 $-8
2014-12-31
Sector Industry Market Cap Revenue
Medical Medical - Biomedical and Genetics $0.448B $0.017B
Selecta Biosciences, Inc. is a biopharmaceutical company which develops targeted immunotherapies and vaccines. Its product pipelineincludes gene therapy, food allergy, malaria; SEL-212, which is a therapeutic enzyme indicated for refractory gout; SEL-070, which is indicated for smoking cessation and relapse prevention; SEL-701, which is indicated for the treatment of human papillomavirus associated cancer and SEL-212 consists of SVP-Rapamycin co-administered with pegsiticase, its pegylated uricase. Selecta Biosciences, Inc. is based in Watertown, United States.
Stock Name Country Market Cap PE Ratio
Bristol Myers Squibb (BMY) United States $129.038B 8.59
Bio-Rad Laboratories (BIO.B) United States $21.730B 46.31
QIAGEN (QGEN) Netherlands $12.127B 20.54
Biohaven Pharmaceutical Holding (BHVN) United States $8.605B 0.00
Emergent Biosolutions (EBS) United States $2.673B 6.45
Arcus Biosciences (RCUS) United States $2.441B 0.00
Myovant Sciences (MYOV) United Kingdom $1.860B 0.00
ADC Therapeutics SA (ADCT) Switzerland $1.754B 0.00
Zymeworks (ZYME) Canada $1.075B 0.00
Ambrx Biopharma (AMAM) United States $0.524B 0.00
SQZ Biotechnologies (SQZ) United States $0.335B 0.00
Enzo Biochem (ENZ) United States $0.158B 15.48